COMPANY

Imagene AI

Profile checked Oct 10, 2026

Raises and deals from press releases

Deal Daiichi Sankyo deal · amount not disclosed · announced Apr 9, 2026 Company release ↗
Source quote
- Apr 9, 2026 · Company release ↗
  “Imagene AI , a pioneer in multimodal AI for precision oncology, today announced a collaboration with Daiichi Sankyo (TSE: 4568) to advance biomarker discovery and response prediction in oncology drug development”

From the company’s own releases; this list is partial. All raises and deals

Oct 1, 2026 Partnership Partnership / licensing announced Oct 1, 2026. Source: company's own press page. source ↗
Apr 9, 2026 Partnership Partnership / licensing announced Apr 9, 2026. Source: company's own press page. source ↗
Oct 29, 2025 Partnership Partnership / licensing announced Oct 29, 2025. Source: company's own press page. source ↗
Jul 1, 2025 Raise Private equity round — Series B: $45M (total, as published), announced Jul 1, 2025. Source: company's own press page. source ↗

Raised: $45.0M. Last 2 years.

Jul 1, 2025 Private equity round — Series B: $45M (total, as published), announced Jul 1, 2025. Source: company's own press page. source ↗
Oct 1, 2026 Partnership / licensing announced Oct 1, 2026. Source: company's own press page. source ↗
Apr 9, 2026 Partnership / licensing announced Apr 9, 2026. Source: company's own press page. source ↗
Oct 29, 2025 Partnership / licensing announced Oct 29, 2025. Source: company's own press page. source ↗